Cell BioEngines Announces Establishment of New R&D Facility to Further Advance Its Platform and Pipeline of Innovative Cell Therapies
(NYSE:JLL), NEW YORK, Jan. 21, 2025 (GLOBE NEWSWIRE) — Cell BioEngines, Inc. (“Cell BioEngines” or the “Company”), a clinical-stage biotechnology company developing a universal 'plug-and-play' allogeneic stem cell therapy platform and a portfolio of 'off-the-shelf' cell therapies for the treatment of hematologic and solid tumor malignancies, announced today that it has signed a new lab […]